EXPERIMENTAL PHYSIOLOGICAL STUDIES WITH LYSERGIC ACID DIETHYLAMIDE (LSD-25)
Archives of Neurology And Psychiatry – May 01, 1951
Source: OpenAlex
Summary
Lysergic acid diethylamide (LSD-25) demonstrates significant effects in both psychotic and normal subjects, with findings confirming earlier studies involving various subject types. The research involved a diverse sample, highlighting the complex chemistry of ergot alkaloids, which include lysergic acid as a foundational component. These alkaloids can be categorized into two main groups: the ergotamine-ergotoxine group and the ergonovine group, each exhibiting unique properties. Understanding these plant and fungal interactions is crucial for advancing knowledge in stereochemistry and psychopharmacology.
Abstract
STOLL1studied the effects of lysergic acid diethylamide (LSD-25) in both psychotic and normal subjects. Condrau2and others reported their results of administration of lysergic acid diethylamide to various types of subjects and in general confirmed the findings of Stoll. For details of the chemistry of the ergot alkaloids, we refer to a more recent, comprehensive work by Stoll.3It should be mentioned in passing that all lysergic acid alkaloids have lysergic acid as a base. This substance is a multiple, active, polycyclic, nitrogenous carboxylic acid, which so far has not been synthesized. The natural ergot alkaloids containd-lysergic acid and may be divided into two groups— the ergotamine-ergotoxine group, on the one hand, and the ergonovine group, on the other. In the former groupd-lysergic acid is combined with a manifold peptid, whereas the latter group comprises the mono acid amides of thed